Leveraging a large language model to predict protein phase transition: A physical, multiscale, and interpretable approach.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
13 Aug 2024
Historique:
medline: 8 8 2024
pubmed: 7 8 2024
entrez: 7 8 2024
Statut: ppublish

Résumé

Protein phase transitions (PPTs) from the soluble state to a dense liquid phase (forming droplets via liquid-liquid phase separation) or to solid aggregates (such as amyloids) play key roles in pathological processes associated with age-related diseases such as Alzheimer's disease. Several computational frameworks are capable of separately predicting the formation of droplets or amyloid aggregates based on protein sequences, yet none have tackled the prediction of both within a unified framework. Recently, large language models (LLMs) have exhibited great success in protein structure prediction; however, they have not yet been used for PPTs. Here, we fine-tune a LLM for predicting PPTs and demonstrate its usage in evaluating how sequence variants affect PPTs, an operation useful for protein design. In addition, we show its superior performance compared to suitable classical benchmarks. Due to the "black-box" nature of the LLM, we also employ a classical random forest model along with biophysical features to facilitate interpretation. Finally, focusing on Alzheimer's disease-related proteins, we demonstrate that greater aggregation is associated with reduced gene expression in Alzheimer's disease, suggesting a natural defense mechanism.

Identifiants

pubmed: 39110734
doi: 10.1073/pnas.2320510121
doi:

Substances chimiques

Amyloid 0
Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2320510121

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Mor Frank (M)

Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520.
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06510.

Pengyu Ni (P)

Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520.
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06510.

Matthew Jensen (M)

Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520.
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06510.

Mark B Gerstein (MB)

Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06520.
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06510.
Department of Computer Science, Yale University, New Haven, CT 06511.
Department of Statistics and Data Science, Yale University, New Haven, CT 06511.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH